Description
Freenome is developing next-generation blood tests for early cancer detection, powered by our multiomics platform. Freenome aims to detect cancer in its earliest stages and subsequently develop new treatments.
Freenome
Freenome
Uses AI systems in screenings, blood test and other diagnostic procedures to test for cancer.
Categories: AI, Diagnoses and Decision
